Platinum sponsors


In the field of neuroscience, with many tough-to-treat disorders and high unmet need, our scientists are relentless in their pursuit of raising the standards of care. But the brain is complex, and new challenges require new ways of thinking across all stages of drug discovery and development.

That’s why we are continuously exploring innovative, disease-modifying approaches to address some of the most prevalent and serious disorders, from Parkinson’s and Alzheimer’s to migraine, schizophrenia and stroke.

We work across all stages of development in search of novel therapeutics and drug-device combinations that have the potential to treat chronic disabling neurological and psychiatric conditions.

Boehringer Ingelheim

We have made a long-term, generational commitment to transform the mental health landscape through our research and collaborations with a variety of like-minded stakeholders. By taking a strategic and intentional precision psychiatry approach, our hope is to design treatments that have the potential to address the brain biology associated with specific symptoms.

Our innovative pipeline of owned and partnered assets represents potential opportunities to make precision psychiatry a reality in indications of high unmet need and sits at the core of our ambition to create a deeper understanding of the drivers of chronic and complex mental health conditions. We go beyond the idea that mental health treatment is just a pill and are driven to provide holistic support through early detection of disease, ongoing psychological and social interventions, as well as prescription digital therapeutics.

We strive to alleviate the burden on people living with mental health conditions, their care partners, loved ones and society.


Merck, a leading science and technology company, operates across life science, healthcare and electronics. More than 64,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. Merck has a long-standing legacy in neurology and immunology, with significant R&D and commercial experience in multiple sclerosis (MS). Merck aims to improve the lives of patients by addressing areas of unmet medical needs. In addition to Merck’s commitment to MS, the company also has a pipeline focusing on discovering new therapies that have potential in other neuroinflammatory and immune-mediated diseases, including systemic lupus erythematosus (SLE) and generalized myasthenia gravis (gMG).


At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We strive to set the standard for quality, safety, and value in the discovery, development, and manufacture of health care products. Our global portfolio includes medicines and vaccines as well as many of the world’s best-known consumer health care products. Every day, Pfizer colleagues work across developed and emerging markets to advance wellness, prevention, treatments, and cures that challenge the most feared diseases of our time. Consistent with our responsibility as one of the world’s premier innovative biopharmaceutical companies, we collaborate with health care providers, governments, and local communities to support and expand access to reliable, affordable health care around the world. For more than 170 years, Pfizer has worked to make a difference for all who rely on us.